DailyDoctor Archive Specialties Get app
Back to the 26 October 2026 edition

Clinical update · 01 of 05

SOX10 in salivary tumours: a pooled positive and negative list

Use SOX10 in a salivary panel to split lineages, and state the clone, especially if it is BC34.

Design
Systematic review and meta-analysis of 35 immunohistochemistry studies
Population
1,146 histological and 35 cytological salivary gland tumour samples
Primary outcome
Pooled SOX10 positivity by tumour type
Effect
Pleomorphic adenoma 95.8%, adenoid cystic 96.6%; Warthin 2.3%, salivary duct 3.7%

This meta-analysis pooled 35 studies of SOX10 immunohistochemistry in 1,146 histological and 35 cytological samples of primary salivary gland tumours.

Pooled positivity was above 90% for pleomorphic adenoma (96%), canalicular adenoma (99%), basal cell adenoma (91%), adenoid cystic carcinoma (97%), acinic cell carcinoma (97%), polymorphous adenocarcinoma (97%), microsecretory carcinoma (96%) and intercalated duct-type intraductal carcinoma (91%). Myoepithelioma was less consistent (75%). Warthin tumour (2%), salivary duct carcinoma (4%), oncocytoma (8%) and apocrine intraductal carcinoma (10%) were essentially negative. Polyclonal antibodies and clones EP268, N-20 and A-2 performed alike; clone BC34 stained fewer positive tumours.

In practice SOX10 is most useful as a split between broadly acinar or intercalated-duct and myoepithelial lineages, which stain, and oncocytic or apocrine-type lesions, which do not. It does not distinguish between the positive entities, so it belongs in a panel, not on its own. Note the clone in your report; a negative result with BC34 means less than one with another clone.

  • Use SOX10 to separate SOX10-positive tumours (pleomorphic adenoma, adenoid cystic, acinic cell) from oncocytic or apocrine-type lesions.
  • A SOX10-positive oncocytic-looking tumour should prompt a second look before calling it oncocytoma or Warthin.
  • A SOX10-negative high-grade carcinoma with apocrine features favours salivary duct carcinoma; confirm with AR.
  • Record the antibody clone in the report — BC34 stains fewer tumours than other clones.
  • Do not rely on SOX10 to tell positive entities apart; combine it with morphology and other markers.

Why it matters

A pooled list replaces scattered series, and the clone difference explains some conflicting results.

The statistics, in plain English

Some confidence intervals run above 100% or below 0% — an artefact of the meta-analysis method with small studies and near-100% or near-0% results. Read them as 'nearly always' or 'nearly never'. Myoepithelioma's wide interval (52% to 98%) means its SOX10 status is genuinely variable.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

ihcsurgpathcytopathmolecularbiomarkers

Tomorrow morning, before your first patient

One edition a day for pathology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app